Craver Josiah
SEC insider (Form 3/4/5 filer). CIK 0002038400. PAO at Faeth Therapeutics, Inc. (FTH). 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 21, 2026. Located in AUSTIN, TX.
Companies Craver Josiah has filed insider reports for
- Faeth Therapeutics, Inc. (FTH): Officer, PAO
Craver Josiah
CIK: 0002038400
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Faeth Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 21, 2026FTH
Faeth Therapeutics, Inc.
AwardDirectPerformance-Based Stock Option (right to buy)
30.8K shares- - Apr 10, 2026SNSE
Sensei Biotherapeutics, Inc.
AwardDirectStock Option (right to buy)
80K shares- - Feb 14, 2025SNSE
Sensei Biotherapeutics, Inc.
AwardDirectStock Option (Right to Buy)
50K shares- - Dec 20, 2024SNSE
Sensei Biotherapeutics, Inc.
AwardDirectStock Option (Right to Buy)
100K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 21, 2026 | FTH Faeth Therapeutics, Inc. | Award Performance-Based Stock Option (right to buy) | 30,824 | - | - | Direct |
| Apr 10, 2026 |  SNSE Sensei Biotherapeutics, Inc. | Award Stock Option (right to buy) | 80,000 | - | - | Direct |
| Feb 14, 2025 | SNSE Sensei Biotherapeutics, Inc. | Award Stock Option (Right to Buy) | 50,000 | - | - | Direct |
| Dec 20, 2024 | SNSE Sensei Biotherapeutics, Inc. | Award Stock Option (Right to Buy) | 100,000 | - | - | Direct |
1-4 of 4 transactions